✦ LIBER ✦

84 TRIAGE MRI FOLLOWED BY MRI-TARGETED BIOPSY FOR MEN WITH PROSTATE CANCER: A DECISION ANALYSIS

✍ Scribed by Willis, Sarah; van der Meulen, Jan; Miners, Alec; Emberton, Mark; Ahmed, Hashim

Book ID: 123432089
Publisher: Lippincott Williams and Wilkins
Year: 2013
Tongue: English
Weight: 200 KB
Volume: 189
Category: Article
ISSN: 0022-5347
DOI: 10.1016/j.juro.2013.02.1462

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

794 Comparison between systematic and MR

794 Comparison between systematic and MRI targeted prostate biopsy for patients with no history of prostate cancer attending a first round of trans-rectal ultrasound biopsy procedure

✍ G. Coffin; G. Chevreau; R. Renard-Penna; E. Comperat; M.A. Vitrani; C. Torteroto 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 34 KB

1466 COULD USE OF MRI IN MEN REFERRED FO

1466 COULD USE OF MRI IN MEN REFERRED FOR RISK OF PROSTATE CANCER RESULT IN A REDUCTION OF BIOPSY RELATED MORBIDITY WHEN COMPARED TO THE ERSPC AND PCPT RISK CALCULATORS FOR DECISION TO BIOPSY?

✍ Dockray, Judith; Coe, Jane; Abu, Victor; Freeman, Alex; Allen, Claire; Emberton, 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 95 KB

Can multiparametric magnetic resonance i

Can multiparametric magnetic resonance imaging predict upgrading of transrectal ultrasound biopsy results at more definitive histology?11Mohamed Abd-Alazeez receives funding from the Egyptian government. Mark Emberton and Hashim U. Ahmed receive funding from USHIFU and Advanced Medical Diagnostics for clinical trials. Mark Emberton is a paid consultant for Steba Biotech, USHIFU and Sanofi-Aventis. Mark Emberton has received research support by GSK for a study evaluating the role of MRI in men with prostate cancer. Mark Emberton and Hashim Ahmed have previously received medical consultancy fees from GE Healthcare/Oncura and Hashim Ahmed previously from Steba Biotech. Mark Emberton is a medical director of Mediwatch PLC. Hashim Uddin Ahmed and Mark Emberton receive funding from the Medical Research Council, the NIHR-HTA, NIHR-i4i, the US NIH/NCI, Pelican Cancer Foundation, Prostate Cancer UK, and St Peter׳s Trust. This work was part funded by research support for Mark Emberton and Alex Kirkham from the UK National Institute of Health Research UCLH/UCL Comprehensive Biomedical Research Centre, London, UK.

✍ Abd-Alazeez, Mohamed; Ahmed, Hashim U.; Arya, Manit; Allen, Clare; Dikaios, Niko 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 415 KB